Navigation Links
Boston Scientific Announces Five-Year, $150 Million Investment in China to Accelerate Commercial Expansion
Date:7/27/2011

ard-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words.  These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance.  These forward-looking statements include, among other things, statements regarding our strategic initiatives, our business and investment plans in China, the market for our products in China and our share of that market, our financial performance in China and other emerging markets, new product launches and launch cadence, regulatory approvals, clinical trials (including clinical trial plans in emerging markets), product performance, training programs and competitive offerings.  If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.  These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release.  As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.  

Factors that may cause such differences include, among other things: future economic, political, environmental, competitive, reimbursement, legal and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and future business decisions made by us and our competitors. 
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... PRINCETON, N.J. , Dec. 24, 2014 /PRNewswire/ ... Company), a late-stage biopharmaceutical company developing products that ... inflammation, oncology and biodefense, announced today that on ... registered public offering. The Company raised ... offering and intends to use the net proceeds ...
(Date:12/24/2014)... FARMINGTON, Conn. , Dec. 24, ... PTN), a biopharmaceutical company developing targeted, receptor-specific peptide ... unmet medical need and commercial potential, today announced ... of 2,050,000 shares of its common stock and ... its common stock.  Funds under the management of ...
(Date:12/24/2014)... Wash. , Dec. 23, 2014  Advanced ... development company engaged primarily in the development of ... therapeutic applications, today announced that it has filed ... Food and Drug Administration ("FDA") for marketing clearance ... Section 513(f)(2) of the U.S. Food, Drug and ...
Breaking Medicine Technology:Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3
... in Neurogastroenterology and Motility- MONTVALE, N.J., Oct. ... announced today the publication of,preclinical data demonstrating the ... of advanced glycated end-products (AGEs) and restore,neuronal nitric ... Loss,of gastrointestinal nNOS activity is one of the ...
... nearly 80% of patients, SAN FRANCISCO, Oct. 24 ... data from an ongoing phase 2,trial of XL880, an ... renal cell carcinoma (PRC). Of 19 patients with measurable,disease ... decrease in,tumor size (4-33%), including one patient with a ...
Cached Medicine Technology:Synvista Therapeutics' Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications 2Synvista Therapeutics' Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications 3Synvista Therapeutics' Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications 4Interim Phase 2 Data for Exelixis' XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer 2Interim Phase 2 Data for Exelixis' XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer 3Interim Phase 2 Data for Exelixis' XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer 4Interim Phase 2 Data for Exelixis' XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer 5
(Date:12/25/2014)... December 26, 2014 This is a ... the global Sterilizers industry with a focus on the ... market status of the Sterilizers manufacturers and is a ... individuals interested in the industry. This report provides a ... and manufacturing technology. In this part, the report presents ...
(Date:12/25/2014)... months the trends for evening dresses shift and ... of the hottest styles in the next few months.” The ... 26 A-line sweetheart evening dresses, and announces the availability of ... trying our best to help a lady to show off ... prices, we provide discounted delivery costs to our customers worldwide. ...
(Date:12/25/2014)... BambooFlooringChina.com sells many bamboo products and the ... the company announces big discounts on its bamboo ... , BambooFlooringChina.com is the world’s leader in bamboo flooring. ... until Jan. 20, 2015. , The bamboo mats are ... natural thread. All the bamboo strips for the mats ...
(Date:12/25/2014)... 25, 2014 (HealthDay News) -- The risk of burns ... so you need to be extra cautious, an expert ... see a significant increase in patients coming in with ... Suffolk County Volunteer Firefighters Burn Center of Stony Brook ... be full of joy, but if not careful, could ...
(Date:12/25/2014)... Thousands of transvaginal mesh lawsuits ( ... number of multidistrict litigations currently underway in U.S. District ... reports. According to an Order issued on December 2, ... Status Conference in all of the proceedings on January ... to submit a proposed agenda to the Court by ...
Breaking Medicine News(10 mins):Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4
... fax orders and associated manual processes in healthcare supply ... customersMISSISSAUGA, Ontario and LOUISVILLE, Colo., Jan. 29 ... fax conversion service to streamline the electronic integration and ... Converting manual fax orders to electronic data interchange (EDI) ...
... Va., Jan. 29 CSC (NYSE: ... benchmarking tool that enables hospitals to analyze how ... areas. The application also provides hospital administrators with ... and improving healthcare delivery. The new tool, available ...
... FRANCISCO, Jan. 29 The SCAN Foundation has awarded ... establish the nation,s first center devoted exclusively to advancing ... community-based care for seniors. "There is a looming crisis ... needs of aging baby boomers," said Bruce Chernof, M.D., ...
... Dietetic Association, the nation,s largest association of food and ... Dietary Guidelines for Americans to make the ... habits more effective in helping Americans achieve better health. ... basis for federal food and nutrition education programs. "Issuing ...
... 29 Nutraceutical International Corporation (Nasdaq: NUTR ) today ... 31, 2008. Net sales for the fiscal 2009 first ... same quarter of fiscal 2008. For the first quarter ... diluted earnings per share, compared to net income of $3.2 ...
... Agencies that Rely on Send Word Now for Rapid, Reliable ... Inc., the leading provider of emergency notification and other on-demand ... of Health has expanded its use of Send Word Now ... extend its use of the SWN Alert Service across its ...
Cached Medicine News:Health News:Covidien Canada Streamlines Integration and Processing of Fax-based Orders With GHX G-Fax(TM) Fax Conversion Service 2Health News:Covidien Canada Streamlines Integration and Processing of Fax-based Orders With GHX G-Fax(TM) Fax Conversion Service 3Health News:CSC Introduces HealthSpace Advisor Benchmarking Tool 2Health News:CSC Introduces HealthSpace Advisor Benchmarking Tool 3Health News:The SCAN Foundation Grants $5 Million to the Health Technology Center to Establish National Center for Technology and Aging 2Health News:The SCAN Foundation Grants $5 Million to the Health Technology Center to Establish National Center for Technology and Aging 3Health News:American Dietetic Association Calls for Accountability in Dietary Guidelines for Americans to Make Them More Effective 2Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 2Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 3Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 4Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 5Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 6Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 7Health News:National Institutes of Health Expands Use of Emergency Notification Services Provided by Send Word Now(TM) Across NIH Campus 2Health News:National Institutes of Health Expands Use of Emergency Notification Services Provided by Send Word Now(TM) Across NIH Campus 3
... IEC-Innovative Endoscopy Components, LLC ... Medical Equipment "Made in ... are manufactured according to ... the most excellent design ...
... The CXDI-40C is a highly sensitive ... 17-inch imaging area and it is designed ... flexible, it comes in multiple wall stand ... Canon technology, the CXDI-40C efficiently produces detailed ...
... Perfect Pupil Injectable was designed to provide ... reduce the risk of surgical complications during cataract ... expansion device for small and medium sized pupils ... consistantly, protects the iris sphincter during surgery, and ...
... ulitizes ultrasonic waves to remove bone cement speedily ... probe liquifies the cement at the point of ... , ,A special feature of the apparatus is ... to signal this to the operator instantly. Probe ...
Medicine Products: